Compare Ares Capital Corporation (ARCC) vs Core Scientific Inc (CORZ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Ares Capital Corporation vs Core Scientific Inc — how do they compare? Ares Capital Corporation trades at $18.77 (market cap $13.48B), while Core Scientific Inc trades at $23.21 (market cap $7.47B). The key difference: Ares Capital Corporation is the larger of the two by market cap, and Ares Capital Corporation pays a 10.22% dividend while Core Scientific Inc pays none. Which is the better fit depends on your goals.
| ARCC | CORZ | |
|---|---|---|
Market Cap | $13.48B | $7.47B |
Sector | Financials | Technology |
52-Week High | $23.25 | $29.16 |
52-Week Low | $17.45 | $12.51 |
Dividend Yield | 10.22% | — |
Enterprise Value | — | $8.52B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ares Capital (ARCC) trades at $18.78, up 2.01% on the day, with a bearish technical signal but strong analyst support. The stock shows a P/E of 11.52 and P/B of 0.96, trading below the consensus price target of $20.58. Recent earnings have missed expectations, with Q2 2026 results pending, while revenue declined to $1.51B in 2025 from $1.7B in 2024. A dividend of $0.48 is scheduled for payment on June 30, 2026, supporting income appeal amid mixed sentiment.
ARCC presents a value opportunity with a high dividend yield and undervaluation relative to analyst targets, but faces headwinds from earnings misses and a bearish technical outlook. Risks include revenue volatility and competitive pressures in the BDC space, though institutional buy ratings suggest confidence in recovery potential. Investors should weigh income stability against growth challenges.
CORZ trades at $23.49, down 1.05% on the day, with a bullish technical signal but bearish moving averages. The company reported Q1 2026 revenue growth driven by AI colocation, yet missed EPS estimates. Strong analyst support exists with 19 buy ratings and a $34.17 consensus target, indicating 45% upside potential.
Outlook remains optimistic due to strategic pivot to AI infrastructure, though significant risks include persistent losses, high cash burn, and execution challenges in scaling data center operations amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ares Capital Corporation
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in U.S. middle-market companies with investment opportunities as well as in larger companies. Its portfolio comprises of first lien senior secured loans, second lien senior secured loans, and mezzanine debt (subordinated unsecured loan), which may include equity components that are diversified by industry and sector. The company may invest in preferred and common equity investments to a lesser proportion. Its revenue mainly consists of interest and dividend income received from the investment made.
Read more on ARCC →About Core Scientific Inc
Core Scientific provides digital infrastructure for Bitcoin mining and high-performance computing (HPC). It operates purpose-built data centers to support digital asset production and AI-related workloads.
Read more on CORZ →
